Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s10753-019-01106-x.

Title:
Salidroside Decreases Atherosclerosis Plaque Formation via Inhibiting Endothelial Cell Pyroptosis | Inflammation
Description:
Pyroptosis, a new pro-inflammatory programmed cell death, is linked to atherosclerosis (AS). Our previous studies suggested that salidroside (SAL) can alleviate AS and exert anti-oxidative and anti-inflammatory properties. However, the effect of SAL on atherosclerosis-related pyroptosis has not been studied. Here, we investigated the effect of SAL on pyroptosis to explain the underlying mechanisms of SAL on atherosclerosis-related inflammation. We established an atherosclerosis mouse model via western diet (HFD) to explore the protective effect of SAL. According to our results, administration of SAL for 12 weeks markedly reduced the atherosclerotic plaque in aorta. Meanwhile, SAL also alleviated the pyroptosis, as evidenced by inhibiting caspase-1 activation, interleukin-1β (IL-1β) release, and TUNEL-positive staining, and decreasing the expression of Gasdermin D (GSDMD). Furthermore, SAL also decreased the activation of caspase-1 and inhibited the release of IL-1β induced by lipopolysaccharide (LPS) and adenosine triphosphate (ATP) in human umbilical vein endothelial cell (HUVECs). Our data indicate that SAL inhibit NLRP3-related pyroptosis, which might be the underlying mechanism of SAL anti-inflammatory in atherosclerosis.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {šŸ“š}

  • Education
  • Telecommunications
  • Health & Fitness

Content Management System {šŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {šŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,016 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {šŸ’ø}

The income method remains a mystery to us.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {šŸ”}

article, google, scholar, cas, pyroptosis, cell, salidroside, atherosclerosis, endothelial, yang, wang, sal, chengdu, zhang, chen, journal, research, inflammation, cells, inflammasome, university, nlrp, liu, death, access, pathway, china, privacy, cookies, content, inhibiting, xing, international, shi, nature, attenuates, cellular, sichuan, hospital, peoples, republic, xss, data, information, publish, search, plaque, published, jin, activation,

Topics {āœ’ļø}

mitochondria-related ampk/pi3k/akt/enos pathway regulating pi3k/pkb/nrf2/nfkappab signaling ampk-dependent txnip/nlrp3 pathway ros/nlrp3/caspase-1 signaling pathway hypoxia-inducible factor-1alpha expression lps-induced inflammatory injury high-fat diet month download article/chapter txnip-nlrp3 inflammasome pathway phosphatidylinositol 3-kinase/protein kinase cell death research human umbilical cords atherosclerosis-related pyroptosis salidroside reduces inflammation il-1β induced related subjects atherosclerosis-related inflammation sirt1-dependent inhibition privacy choices/manage cookies full article pdf article inflammation aims nlrp3 inflammasome activation ki mice fed dying eukaryotic cells laboratory animals published yu-ting yang wen-jing li exert anti-oxidative inhibiting caspase-1 activation european economic area article xing anti-inflammatory properties animal ethics committee endothelial cells atherosclerotic plaque tunel-positive staining clinica chimica acta forming membrane pores complement c3 activity evidence-based complementary extracellular matrix accumulation chemico-biological interactions 278 interleukin-1beta secretion cell research 25 cell death atherosclerosis mouse model nicotine promotes atherosclerosis conditions privacy policy anti-atherosclerotic effects sal anti-inflammatory

Schema {šŸ—ŗļø}

WebPage:
      mainEntity:
         headline:Salidroside Decreases Atherosclerosis Plaque Formation via Inhibiting Endothelial Cell Pyroptosis
         description:Pyroptosis, a new pro-inflammatory programmed cell death, is linked to atherosclerosis (AS). Our previous studies suggested that salidroside (SAL) can alleviate AS and exert anti-oxidative and anti-inflammatory properties. However, the effect of SAL on atherosclerosis-related pyroptosis has not been studied. Here, we investigated the effect of SAL on pyroptosis to explain the underlying mechanisms of SAL on atherosclerosis-related inflammation. We established an atherosclerosis mouse model via western diet (HFD) to explore the protective effect of SAL. According to our results, administration of SAL for 12 weeks markedly reduced the atherosclerotic plaque in aorta. Meanwhile, SAL also alleviated the pyroptosis, as evidenced by inhibiting caspase-1 activation, interleukin-1β (IL-1β) release, and TUNEL-positive staining, and decreasing the expression of Gasdermin D (GSDMD). Furthermore, SAL also decreased the activation of caspase-1 and inhibited the release of IL-1β induced by lipopolysaccharide (LPS) and adenosine triphosphate (ATP) in human umbilical vein endothelial cell (HUVECs). Our data indicate that SAL inhibit NLRP3-related pyroptosis, which might be the underlying mechanism of SAL anti-inflammatory in atherosclerosis.
         datePublished:2020-02-19T00:00:00Z
         dateModified:2020-02-19T00:00:00Z
         pageStart:433
         pageEnd:440
         sameAs:https://doi.org/10.1007/s10753-019-01106-x
         keywords:
            salidroside
            pyroptosis
            GSDMD, atherosclerosis
            endothelial cells
            Immunology
            Rheumatology
            Pharmacology/Toxicology
            Pathology
            Internal Medicine
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-019-01106-x/MediaObjects/10753_2019_1106_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-019-01106-x/MediaObjects/10753_2019_1106_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-019-01106-x/MediaObjects/10753_2019_1106_Fig3_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-019-01106-x/MediaObjects/10753_2019_1106_Fig4_HTML.png
         isPartOf:
            name:Inflammation
            issn:
               1573-2576
               0360-3997
            volumeNumber:43
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer US
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Sha-Sha Xing
               affiliation:
                     name:Affiliated Hospital of Chengdu University
                     address:
                        name:Clinical Drug Trial Institution, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jin Yang
               affiliation:
                     name:Affiliated Hospital of Chengdu University
                     address:
                        name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:Wen-jing Li
               affiliation:
                     name:Zhongnan Hospital of Wuhan University
                     address:
                        name:Department of Pharmacy, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jian Li
               affiliation:
                     name:Chengdu University School of Medicine
                     address:
                        name:Department of Basic Medicine, Chengdu University School of Medicine, Chengdu, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Lin Chen
               affiliation:
                     name:Affiliated Hospital of Chengdu University
                     address:
                        name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Yu-ting Yang
               affiliation:
                     name:Affiliated Hospital of Chengdu University
                     address:
                        name:Clinical Drug Trial Institution, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xia Lei
               affiliation:
                     name:Affiliated Hospital of Chengdu University
                     address:
                        name:Clinical Drug Trial Institution, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jun Li
               affiliation:
                     name:Chengdu University
                     address:
                        name:Department of General Surgery, Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Kai Wang
               affiliation:
                     name:Affiliated Hospital of Chengdu University
                     address:
                        name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Xun Liu
               affiliation:
                     name:Affiliated Hospital of Chengdu University
                     address:
                        name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Salidroside Decreases Atherosclerosis Plaque Formation via Inhibiting Endothelial Cell Pyroptosis
      description:Pyroptosis, a new pro-inflammatory programmed cell death, is linked to atherosclerosis (AS). Our previous studies suggested that salidroside (SAL) can alleviate AS and exert anti-oxidative and anti-inflammatory properties. However, the effect of SAL on atherosclerosis-related pyroptosis has not been studied. Here, we investigated the effect of SAL on pyroptosis to explain the underlying mechanisms of SAL on atherosclerosis-related inflammation. We established an atherosclerosis mouse model via western diet (HFD) to explore the protective effect of SAL. According to our results, administration of SAL for 12 weeks markedly reduced the atherosclerotic plaque in aorta. Meanwhile, SAL also alleviated the pyroptosis, as evidenced by inhibiting caspase-1 activation, interleukin-1β (IL-1β) release, and TUNEL-positive staining, and decreasing the expression of Gasdermin D (GSDMD). Furthermore, SAL also decreased the activation of caspase-1 and inhibited the release of IL-1β induced by lipopolysaccharide (LPS) and adenosine triphosphate (ATP) in human umbilical vein endothelial cell (HUVECs). Our data indicate that SAL inhibit NLRP3-related pyroptosis, which might be the underlying mechanism of SAL anti-inflammatory in atherosclerosis.
      datePublished:2020-02-19T00:00:00Z
      dateModified:2020-02-19T00:00:00Z
      pageStart:433
      pageEnd:440
      sameAs:https://doi.org/10.1007/s10753-019-01106-x
      keywords:
         salidroside
         pyroptosis
         GSDMD, atherosclerosis
         endothelial cells
         Immunology
         Rheumatology
         Pharmacology/Toxicology
         Pathology
         Internal Medicine
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-019-01106-x/MediaObjects/10753_2019_1106_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-019-01106-x/MediaObjects/10753_2019_1106_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-019-01106-x/MediaObjects/10753_2019_1106_Fig3_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs10753-019-01106-x/MediaObjects/10753_2019_1106_Fig4_HTML.png
      isPartOf:
         name:Inflammation
         issn:
            1573-2576
            0360-3997
         volumeNumber:43
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer US
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Sha-Sha Xing
            affiliation:
                  name:Affiliated Hospital of Chengdu University
                  address:
                     name:Clinical Drug Trial Institution, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jin Yang
            affiliation:
                  name:Affiliated Hospital of Chengdu University
                  address:
                     name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:Wen-jing Li
            affiliation:
                  name:Zhongnan Hospital of Wuhan University
                  address:
                     name:Department of Pharmacy, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jian Li
            affiliation:
                  name:Chengdu University School of Medicine
                  address:
                     name:Department of Basic Medicine, Chengdu University School of Medicine, Chengdu, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Lin Chen
            affiliation:
                  name:Affiliated Hospital of Chengdu University
                  address:
                     name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Yu-ting Yang
            affiliation:
                  name:Affiliated Hospital of Chengdu University
                  address:
                     name:Clinical Drug Trial Institution, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xia Lei
            affiliation:
                  name:Affiliated Hospital of Chengdu University
                  address:
                     name:Clinical Drug Trial Institution, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jun Li
            affiliation:
                  name:Chengdu University
                  address:
                     name:Department of General Surgery, Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Kai Wang
            affiliation:
                  name:Affiliated Hospital of Chengdu University
                  address:
                     name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Xun Liu
            affiliation:
                  name:Affiliated Hospital of Chengdu University
                  address:
                     name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Inflammation
      issn:
         1573-2576
         0360-3997
      volumeNumber:43
Organization:
      name:Springer US
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Affiliated Hospital of Chengdu University
      address:
         name:Clinical Drug Trial Institution, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
         type:PostalAddress
      name:Affiliated Hospital of Chengdu University
      address:
         name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
         type:PostalAddress
      name:Zhongnan Hospital of Wuhan University
      address:
         name:Department of Pharmacy, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of China
         type:PostalAddress
      name:Chengdu University School of Medicine
      address:
         name:Department of Basic Medicine, Chengdu University School of Medicine, Chengdu, People’s Republic of China
         type:PostalAddress
      name:Affiliated Hospital of Chengdu University
      address:
         name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
         type:PostalAddress
      name:Affiliated Hospital of Chengdu University
      address:
         name:Clinical Drug Trial Institution, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
         type:PostalAddress
      name:Affiliated Hospital of Chengdu University
      address:
         name:Clinical Drug Trial Institution, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
         type:PostalAddress
      name:Chengdu University
      address:
         name:Department of General Surgery, Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, People’s Republic of China
         type:PostalAddress
      name:Affiliated Hospital of Chengdu University
      address:
         name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
         type:PostalAddress
      name:Affiliated Hospital of Chengdu University
      address:
         name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Sha-Sha Xing
      affiliation:
            name:Affiliated Hospital of Chengdu University
            address:
               name:Clinical Drug Trial Institution, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Jin Yang
      affiliation:
            name:Affiliated Hospital of Chengdu University
            address:
               name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:Wen-jing Li
      affiliation:
            name:Zhongnan Hospital of Wuhan University
            address:
               name:Department of Pharmacy, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Jian Li
      affiliation:
            name:Chengdu University School of Medicine
            address:
               name:Department of Basic Medicine, Chengdu University School of Medicine, Chengdu, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Lin Chen
      affiliation:
            name:Affiliated Hospital of Chengdu University
            address:
               name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Yu-ting Yang
      affiliation:
            name:Affiliated Hospital of Chengdu University
            address:
               name:Clinical Drug Trial Institution, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Xia Lei
      affiliation:
            name:Affiliated Hospital of Chengdu University
            address:
               name:Clinical Drug Trial Institution, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Jun Li
      affiliation:
            name:Chengdu University
            address:
               name:Department of General Surgery, Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Kai Wang
      affiliation:
            name:Affiliated Hospital of Chengdu University
            address:
               name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
               type:PostalAddress
            type:Organization
      name:Xun Liu
      affiliation:
            name:Affiliated Hospital of Chengdu University
            address:
               name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Clinical Drug Trial Institution, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
      name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
      name:Department of Pharmacy, Zhongnan Hospital of Wuhan University, Wuhan, People’s Republic of China
      name:Department of Basic Medicine, Chengdu University School of Medicine, Chengdu, People’s Republic of China
      name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
      name:Clinical Drug Trial Institution, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
      name:Clinical Drug Trial Institution, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
      name:Department of General Surgery, Affiliated Hospital of Chengdu University, Chengdu University, Chengdu, People’s Republic of China
      name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
      name:Department of Urology, Affiliated Hospital of Chengdu University, Chengdu, People’s Republic of China
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {šŸ”—}(93)

Analytics and Tracking {šŸ“Š}

  • Google Tag Manager

Libraries {šŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {šŸ“¦}

  • Crossref

3.85s.